The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

Louisiana has community health centers that can provide low- or no-cost pap smears and gynecological screenings, encouraging ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

January is Cervical Cancer Awareness Month, shining a spotlight on one of the most preventable forms of cancer thanks to the ...

During January, which is National Cervical Cancer Awareness Month, consider this fact: HPV, or human papillomavirus, causes ...

Findings from a phase I trial (NCT04183166) evaluating TG4050, a neoantigen therapeutic vaccine, in patients with operable, ...

A single dose of either bivalent or nonvalent HPV vaccine was just as protective as the standard two doses of either vaccine ...

HPV can lead to six types of cancer: cervical, anal, oropharyngeal (throat), penile, vulvar, and vaginal cancers. The ...

There are no HPV vaccination plans for 2026, and the application pages on municipal websites, which had stepped in to fill ...